glp 1 drugs and levothyroxine Does drug affect thyroid cancer risk? Glucagon-like peptide 1 receptor agonist
Description
Similarly, interrupted use was associated with increased MACE risk, with IRRs of 1.12 for one year and 1.16 for two years of interruption, with effect sizes differing modestly depending on prior treatment duration
[DOI] [PMC free article] [PubMed] [Google Scholar] 72.Samms RJ, et al
Sci Transl Med 2023
Methods like the IUD, implant, patch, ring, or injection are not affected by GLP-1s and are considered reliable
RinellaMENeuschwander-TetriBASiddiquiMSAbdelmalekMFCaldwellSBarbDet al
In T 1 DM, an autoimmune mechanism impairs -cells, leading to insulin deficiency, whereas T 2 DM is characterized by insulin resistance and impaired glucose regulation, where the peripheral action of insulin is compromised (3)
